Passive and active stabilization of dopamine in the striatum

Bioscience Hypotheses

Volumn 2, Issue 4, 2009, Pages 240-244

  Reed, Michael C ^a   Best, Janet ^b   Nijhout, H Frederik ^a  

^a DUKE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Dopamine; Mathematical model; Parkinson's disease; Passive stabilization

Indexed keywords

AUTORECEPTOR; DOPAMINE;

ARTICLE; CELL DEATH; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; HOMEOSTASIS; HUMAN; MATHEMATICAL MODEL; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; SUBSTANTIA NIGRA;

ANIMALIA;

EID: 70350068571     PISSN: 17562392     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bihy.2009.03.008     Document Type: Article

References (29)

1. Feldman R.S., Meyer J.S., and Quenzer L.F. Principles of neuropharmacology (1997), Sinauer Associates, Inc., Sunderland, MA
2. Carlsson A. Perspectives on the discovery of central monoaminergic neurotransmission. Annu Rev Neurosci 10 (1987) 19-40
3. Cooper J.R., Bloom F.E., and Roth R.H. The biochemical basis of neuropharmacology (2003), Oxford University Press, New York, NY
4. Zygmond M.J., Abercrombie E.D., Berger T.W., Grace A.A., and Stricker E.M. Compensation after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci 13 (1990) 290-296
5. Agid Y. Parkinson's disease: pathophysiology. Lancet 337 (1991) 1321-1324
6. Dentresangle C., Le Cavorsin M., Savasta M., and Leviel V. Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra. Brain Res 893 (2001) 178-185
7. Bezard E., Dovero S., Prunier C., Ravenscroft P., Chalon S., Guilloteau D., et al. Relationship between the appearance of symptoms and the level nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine-lesioned macaque model of Parkinson's disease. J Neurosci 21 (2001) 6853-6861
8. Bergstrom B.P., and Garris P.A. "Passive stabilization" of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6-OHDA-lesioned rat. J Neurochem 87 (2003) 1224-1236
9. Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 18 (1966) 925-964
10. Zygmond M.J., Acheson A.L., Stachowiak M.K., and Stricker E.M. Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical Parkinsonism. Arch Neurol 41 (1984) 856-861
11. Stanic D., Parish C.L., Zhu W.M., Krstew E.V., Lawrence A.J., Drago J., et al. Changes in function and ultrastructure of striatal dopaminergic terminals that regenerate following partial lesions of the SNpc. J Neurochem 86 (2003) 329-343
12. Garris P.A., and Wightman R.M. Different kinetics govern dopaminergic neurotransmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J Neurosci 14 (1994) 442-450
13. Garris P.A., Walker Q.D., and Wightman R.M. Dopamine release and uptake both decrease in the partially denervated striatum in proportion to the loss of dopamine terminals. Brain Res 753 (1997) 225-234
14. Best, J, Nijhout, HF, Reed, MC. Homeostatic mechanisms in dopamine synthesis and release, submitted for publication.
15. Cragg S.J., Nicholson C., June K.-K., Lian T., and Rice M.E. Dopamine-mediated volume transmission in midbrain is regulated by distinct extracellular geometry and uptake. J Neurophysiol 85 (2001) 1761-1771
16. Schmitz Y., Benoit-Marand M., Gonon F., and Sulzer D. Presynaptic regulation of dopaminergic neurotransmission. J Neurochem 87 (2003) 273-289
17. Jones S.R., Gainetdinov R.R., Jaber M., Giros B., Wightman R.M., and Caron M.G. Profound neuronal plasticity in response to inactivation of the dopamine transporter. PNAS 95 (1998) 4029-4034
18. Sotnikova T.D., Beaulieu J.-M., Barak L.S., Wetsel W.C., Caron M.G., and Gainetdinov R.R. Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease. PLOS Biol 3 (2005) 1488-1500
19. Zhou F.M., Wilson C., and Dani J.A. Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems. Neuroscientist 9 (2003) 23-36
20. Zeiss C.J. Animal models. Neuroanatomical phenotyping in the mouse: the dopaminergic system. Vet Pathol 42 (2005) 753-773
21. Walters J.R., and Roth R.H. Dopaminergic neurons: drug-induced antagonism of the increase in tyrosine hydroxylase activity produced by cessation of impulse flow. J Pharmacol Exp Ther 191 (1974) 82-91
22. Tissari A.H., and Lillgals M.S. Reduction of dopamine synthesis inhibition by dopamine autoreceptor activation in striatal synaptosomes with in vivo resperine administration. J Neurochem 61 (1993) 231-238
23. Urban J.D., Vargas G.A., von Zastrow M., and Mailman R.B. Aripriprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways. Neuropsychopharmacology 32 (2007) 67-77
24. Alter C.A., Marien M.R., and Marschall J.F. Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: implications for behavioral recovery from brain injury. J Neurochem 48 (1987) 390-399
25. Wightman R.M., Amatore C., Engstrom R.C., Hale P.D., Kristensen E.W., Kuhr W.G., et al. Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience 25 (1998) 513-523
26. Wightman R.M., and Zimmermann J.B. Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake. Brain Res 15 (1990) 135-144
27. Salahpour A., Ramsey A.J., Medvedev I.O., Kile B., Sotnikova T.D., Holmstrand E., et al. Increased amphetamine-induced hyperactivity and reward in mice over-expressing the dopamine transporter. PNAS 105 (2008) 4405-4410
28. Knobelman D.A., Hen R., and Lucki I. Genetic regulation of extracellular serotonin by 5-hydroxytryptamine1A and 5-hydroxytryptamine1B in different brain regions of the mouse. J Pharmacol Exp Ther 298 (2001) 1083-1091
29. Bradberry C.W., and Rubino S.R. Phasic alterations in dopamine and serotonin release in striatum and prefrontal cortex in response to cocaine: predictive cues in behaving rhesus macaques. Neuropsychopharmacology 29 (2004) 676-685